Market Signals

Izalontamab Brengitecan (Iza-Bren) Doubles Median Progression-Free Survival in Patients with Previously-Treated EGFR-Mutated Non-Small Cell Lung Cance

Trump invokes 9/11 in urging Michigan voters to oppose Muslim Senate candidate El-Sayed

How does physical AI "break through" scenario implementation? The steel answer at Unitree's ecosystem conference

Jamia Millia Islamia Files Police Complaint Against Congress MPs For Trespassing During Stir

Eli Lilly (LLY) Reports Strong Phase 1 Ovarian Cancer Data

Xencor reports promising kidney cancer drug results, plans late-stage trial

Democrats, voting-rights groups challenge Trump's bid to block Alaska Senate certification

Summit Therapeutics reports survival benefit for cancer drug in trial

Anthropic Wanted to Replace Engineers. Instead, They Shot Their Own Customers

Akeso says ivonescimab plus chemo beat durvalumab plus chemo on overall survival in first-line biliary tract cancer, with Phase III HARMONi-GI1 also h

Leads Biolabs' LBL-034 Shows 21.8-Month Median PFS in First-in-Human RRMM Data at ESMO 2026, Validating Its Proprietary TCE Platform

Trump casts his midterm election ballot early in Florida

Libtayo® (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneo

Obama, in Ohio, assails 'cruelty' and indecency from Trump and his allies in the midterm campaign

UBS may cut 12,000 Swiss jobs if capital rules tighten - report

2026 ESMO | Innovent Announcement Phase 2 Data Presentation for IBI354 (HER2 ADC) In First-line Treatment of Breast Cancer

2026 ESMO | Innovent Presented Phase 1 Study Data for IBI3001, a First-in-Class EGFR/B7H3 Bispecific ADC

Civil servant who juggled five jobs says he was 'surprised' to be charged with fraud

Vertex Pharmaceuticals (VRTX) Posts Positive Phase 3 Results For Povetacicept

Climb Bio Presents Initial PrisMN Phase 2 Data from Budoprutug in pMN at an Oral Session at ASN Kidney Week 2026

Audi is set to build a US factory in Georgia, per a source, with Trump announcing the plan. Another automaker buying tariff insulation with capex inst

UnitedHealth is up 24.3% YTD and still screens cheap at 23.6x earnings versus a 25.7x sector average and 29.7x peer group. It raised 2026 adjusted EPS

SLB (SLB) Opens Canada Facility After Data Center Win Changed The Story

Moody's holds steady on France's credit rating as country grapples with turmoil and higher yields

argenx (ENXTBR:ARGX) Reports Positive Phase 3 Data In Autoimmune Myositis

Congress Never Followed Constitution, Trying To Create Anarchy: BJP Chief

"Anti-Hindu": BJP Attacks Congress After Lord Ram Idol Moved From Hyderabad Crossing

Moonshot has released major model upgrade every 3 months this yr w/ 2.5, then 2.6, then 3 & now 3.1. The last 2 have been close to SOTA @ time of rele

Junshi Biosciences Announces Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS203 in Combination with Chemotherapy for the Treatm

Phase 3 Cancer Trial Win Could Be A Game Changer For Innovent Biologics Stock

Bitcoin is trying to hold support above $81K while Brent crude prints its highest since March. The oil bid is the macro tell: if crude keeps running,

Democratic socialist set to become D.C. mayor — and face Trump's pushback

Congress MP Detained During Jamia Millia Islamia Protests As Students Demand Union Polls

American Express is cutting 5% of its workforce to 'prepare for AI'

Part 572; Anthropomorphic Test Devices; Test Device for Human Occupant Restraint 50th Percentile Adult Male Dummy (THOR-50M); Extension of Comment Per

How AI Power Board Launches At Navitas Semiconductor (NVTS) Has Changed Its Investment Story

Treasury Yields Snapshot: October 23, 2026

Christine Lagarde: IMFC Statement

Amgen (AMGN) Reports Positive Phase 3 TEZSPIRE Results In Eosinophilic Esophagitis

BE Q3 Earnings Beat Estimates on Strong Product Sales, View Up

Genmab stock surges 9% following positive phase 3 ovarian cancer trial results

ASML (ENXTAM:ASML) Stock Fair Value Edges Higher After Mixed Analyst Revisions

Ionis partner Roche announces new Phase 3 data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN)

Silicon Valley Democrats demand investigation into Starlink restrictions in Ukraine

Locking in Gains: Portfolio Discipline Triggers IQVIA Holding (IQV) Trim After Q2 Beat

Genmab Announces Rinatabart Sesutecan (Rina-S®) Demonstrates Statistically Significant Improvement in Progression-Free Survival and Overall Survival i

NEM Q3 Earnings Beat Estimates on Higher Gold Prices, Strong Sales

ASML Holding N.V. (ASML) Benefits From Demand for Advanced Semiconductor Manufacturing

TeraWulf Inc. (WULF) Shares Retreat as Investors Reassess AI Data Center Growth Prospects

Twist Bioscience Corporation (TWST) Leads Polen’s Small-Mid Growth Portfolio on Record Revenue and AI-Driven Demand